Back to Search
Start Over
Efficacy of Extensive Ablation for Persistent Atrial Fibrillation With Trigger-Based vs. Substrate-Based Mechanisms ― A Prespecified Subanalysis of the EARNEST-PVI Trial ―
- Source :
- Circulation Journal. 85:1897-1905
- Publication Year :
- 2021
- Publisher :
- Japanese Circulation Society, 2021.
-
Abstract
- Background Extensive ablation in addition to pulmonary vein isolation (PVI) would be effective for modification of non-pulmonary vein (non-PV) substrates, whereas PVI might be sufficient for elimination of PV triggers. This study aimed to test the hypothesis that in patients with reproducible atrial fibrillation (AF) triggered by premature atrial contractions originating only from PVs, PVI alone can be sufficient to maintain sinus rhythm.Methods and Results:This study is a prespecified subanalysis of the EARNEST-PVI randomized controlled trial. This study investigated the efficacy of the PVI-alone strategy (PVI-alone) in comparison with the extensive strategy (PVI-plus) for persistent AF with a trigger-based mechanism vs. a substrate-based mechanism. Patients were stratified into 3 groups based on AF mechanisms: (1) Substrate group (N=236); (2) PV trigger group (N=236); and (3) non-PV trigger group (N=24). The hazard ratios for AF recurrence of the PVI-alone strategy with reference to the PVI-plus strategy were 1.456 (95% confidence interval [CI] [0.864-2.452]) in the substrate group, 1.648 (95% CI 0.969-2.801) in the PV trigger group, and 0.937 (95% CI 0.252-3.488) in the non-PV trigger group. No significant interaction between ablation strategy and AF mechanism was observed (P for interaction=0.748). Conclusions This study indicated that the efficacies of the PVI-alone strategy compared with the PVI-plus strategy were consistent across persistent AF with trigger-based and substrate-based mechanisms.
- Subjects :
- medicine.medical_specialty
Premature atrial contraction
medicine.medical_treatment
030204 cardiovascular system & hematology
law.invention
Pulmonary vein
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
Recurrence
law
Internal medicine
Atrial Fibrillation
medicine
Humans
030212 general & internal medicine
Vein
business.industry
Hazard ratio
Atrial fibrillation
General Medicine
medicine.disease
Ablation
Confidence interval
Treatment Outcome
medicine.anatomical_structure
Pulmonary Veins
Catheter Ablation
Cardiology
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- ISSN :
- 13474820 and 13469843
- Volume :
- 85
- Database :
- OpenAIRE
- Journal :
- Circulation Journal
- Accession number :
- edsair.doi.dedup.....ff25d3810a06d388c0f59fb5fed2ff2e
- Full Text :
- https://doi.org/10.1253/circj.cj-21-0126